Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Medical School to Serve as Exiqon MicroRNA Center of Excellence

NEW YORK (GenomeWeb News) – Scientists at Harvard Medical School and its related institutions will use Exiqon's Locked Nucleic Acid microRNA Knockdown Library for high-throughput screening of small molecule and RNAi libraries, the Danish company said today.

Under the agreement, Harvard's ICCB-Longwood Screening Facility will serve as a microRNA Screening Center of Excellence, enabling it to provide the Exiqon technology to a new consortium of investigators at and affiliated with Harvard.

The Knockdown Library contains more than 900 specific inhibitors, and it incorporates Exiqon's LNA detection technology.

"There is a great deal of interest in our community in using miRNA knockdown reagents to study disease-related biology," Neil Kubica, a research fellow in cell biology at Harvard Medical School and the consortium's coordinator, said in a statement.

Financial terms of the agreement were not released.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.